Caris MI Exome™
Whole Exome Sequencing (DNA)
Caris MI Exome™ is a high-throughput, next-generation sequencing-based assay that analyzes the whole human exome of approximately 22,000 DNA genes. Caris MI Exome is included with all Caris Molecular Intelligence orders at no additional cost or increase in average turnaround time.
RNA – Superior Method for Fusion Detection,
Caris Molecular Intelligence® tumor profiling includes Caris MI Transcriptome™, Whole Transcriptome Sequencing (WTS), via RNA next-generation sequencing. Caris MI Transcriptome enables gene fusion and splice variant detection from one streamlined test. RNA testing identifies fusions independent of the breakpoints in DNA and, therefore, has the ability to detect rare, novel fusion events better than DNA-based methods.
RNA-Based Fusion Analysis of NTRK1/2/3 Finds 50% More Clinically Actionable NTRK3 Fusion Partners than DNA.
Caris MI Transcriptome™ Whole Transcriptome Sequencing (RNA),
Caris MI Transcriptome™ is a high-throughput RNA sequencing of the whole transcriptome of approximately 22,000 genes that enables gene fusion detection, RNA splice variant detection and gene expressions analysis all from one streamlined test.